ReShape Lifesciences Inc. (NASDAQ:RSLS – Free Report) CFO Thomas Stankovich bought 17,702 shares of ReShape Lifesciences stock in a transaction dated Friday, June 30th. The shares were purchased at an average cost of $1.52 per share, for a total transaction of $26,907.04. Following the completion of the transaction, the chief financial officer now owns 23,490 […]
Shares of ReShape Lifesciences Inc. (OTCMKTS:RSLS – Get Rating) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.84 and traded as high as $3.34. ReShape Lifesciences shares last traded at $3.02, with a volume of 105,093 shares. ReShape Lifesciences Trading […]